YUYUPHARMA(1P)

The current price of 000225 is 4970 KRW — it has decreased by 2.65% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange YUYUPHARMA(1P) stocks are traded under the ticker 000225.

000225 stock is 3.98% volatile and has beta coefficient of 0.40. Check out the list of the most volatile stocks — is YUYUPHARMA(1P) there?

Yes, you can track YUYUPHARMA(1P) financials in yearly and quarterly reports right on TradingView.

000225 stock has risen by 0.30% compared to the previous week, the month change is a 10.70% fall, over the last year YUYUPHARMA(1P) has showed a 22.42% decrease.

000225 net income for the last quarter is ‪−1.09 B‬ KRW, while the quarter before that showed ‪−2.73 B‬ KRW of net income which accounts for 60.22% change. Track more YUYUPHARMA(1P) financial stats to get the full picture.

Yes, 000225 dividends are paid annually. The last dividend per share was 110.00 KRW. As of today, Dividend Yield (TTM)% is 2.23%. Tracking YUYUPHARMA(1P) dividends might help you take more informed decisions.

Like other stocks, 000225 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade YUYUPHARMA(1P) stock right from TradingView charts — choose your broker and connect to your account.

000225 reached its all-time high on Apr 20, 2021 with the price of 27200 KRW, and its all-time low was 760 KRW and was reached on May 18, 2004.
See other stocks reaching their highest and lowest prices.

As of Apr 23, 2024, the company has 259.00 employees. See our rating of the largest employees — is YUYUPHARMA(1P) on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So YUYUPHARMA(1P) technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating YUYUPHARMA(1P) stock shows the sell signal. See more of YUYUPHARMA(1P) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. YUYUPHARMA(1P) EBITDA is ‪4.86 B‬ KRW, and current EBITDA margin is 3.54%. See more stats in YUYUPHARMA(1P) financial statements.